Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Hyperthermia × Oxaliplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 79 Colorectal Neoplasms 73 Rectal Neoplasms 46 Colonic Neoplasms 26 Pancreatic Neoplasms 22 Carcinoma, Hepatocellular 18 Neoplasm Metastasis 17 Esophageal Neoplasms 10 Cholangiocarcinoma 8 Neoplasms 7 Lymphoma, Large B-Cell, Diffuse 7 Liver Neoplasms 7 Biliary Tract Neoplasms 6 Colorectal Cancer Metastatic 5 Carcinoma, Non-Small-Cell Lung 5 Recurrence 4 Lymphoma, Extranodal NK-T-Cell 4 Gallbladder Neoplasms 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Locally Advanced Rectal Cancer 3 Gastrointestinal Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Solid Tumors 2 Solid Tumor 2 Ovarian Neoplasms 2 Neurotoxicity Syndromes 2 Lymphoma 2 Lung Neoplasms 2 Locally Advanced Colon Cancer 2 Digestive System Neoplasms 2

Interventions

Diathermy 8 Radiotherapy 3 Radiation 2 Fluorouracil 2 Drug Therapy 2 Cisplatin 2 Capecitabine 2 Radiation Dose Hypofractionation 1 Oxaliplatin 1 Mitomycin 1 Immune Checkpoint Inhibitors 1 Gemcitabine 1 Doxorubicin 1 Docetaxel 1 Cyclophosphamide 1 Chemoradiotherapy 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01716949 2017-08-11

HyRec

University of Erlangen-Nürnberg Medical School

Phase 1/2 Unknown

Gastrointestinal

Hyperthermia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡